Cargando…

Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice

Targeting cell cycle has become the gold standard for metastatic breast cancer (MBC), being cyclin-dependent kinase inhibitors (CDKIs) cornerstones of its treatment, alongside radiotherapy (RT). To date, no definite evidence regarding safety and efficacy of the combination of CDKIs plus radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagliano, Ambrogio, Prestifilippo, Angela, Cantale, Ornella, Ferini, Gianluca, Fisichella, Giacomo, Fontana, Paolo, Sciacca, Dorotea, Giuffrida, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247460/ https://www.ncbi.nlm.nih.gov/pubmed/34221963 http://dx.doi.org/10.3389/fonc.2021.643155

Ejemplares similares

Chemical inhibitors of cyclin-dependent kinase (CDKi) improve pancreatic endocrine differentiation of iPS cells
por: Ning, Heming, et al.
Publicado: (2023)

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
por: Puliafito, Ivana, et al.
Publicado: (2022)

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
por: Bonelli, Patrizia, et al.
Publicado: (2014)

Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
por: Puliafito, Ivana, et al.
Publicado: (2023)

HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma
por: He, Shiwei, et al.
Publicado: (2018)

Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73
por: Lam, Frankie, et al.
Publicado: (2014)

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
por: Gampenrieder, Simon Peter, et al.
Publicado: (2021)

CDKI-73 Is a Novel Pharmacological Inhibitor of Rab11 Cargo Delivery and Innate Immune Secretion
por: Sorvina, Alexandra, et al.
Publicado: (2020)

Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer
por: González-Conde, Miriam, et al.
Publicado: (2021)

Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report
por: Puliafito, Ivana, et al.
Publicado: (2020)

Adjuvant tamoxifen for male breast cancer (MBC).
por: Ribeiro, G., et al.
Publicado: (1992)

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress
por: Joaquin, Manel, et al.
Publicado: (2012)

MBC and ECBL libraries: outstanding tools for drug discovery
por: Ginex, Tiziana, et al.
Publicado: (2023)

New Treatment in Advanced Thyroid Cancer
por: Giuffrida, Dario, et al.
Publicado: (2012)

Correspondence: Confirmation of Uterotrophic Activity for 4-MBC in the Immature Rat
por: Ashby, J
Publicado: (2001)

Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012)

Case report and literature review on a large MBC with ulceration
por: Luo, Qin-Qin, et al.
Publicado: (2023)

Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib
por: Puliafito, Ivana, et al.
Publicado: (2022)

BAY 61-3606, CDKi, and sodium butyrate treatments alter gene expression in human vestibular schwannomas and cause cell death in vitro
por: Mitra, Rohan, et al.
Publicado: (2012)

Predicting Resistance by Mutagenesis: Lessons from 45 Years of MBC Resistance
por: Hawkins, Nichola J., et al.
Publicado: (2016)

Prostate cancer – Advantages and disadvantages of MR-guided RT
por: Murray, Julia, et al.
Publicado: (2019)

Lattice or Oxygen-Guided Radiotherapy: What If They Converge? Possible Future Directions in the Era of Immunotherapy
por: Ferini, Gianluca, et al.
Publicado: (2021)

The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)
por: Lee, Ji Yun, et al.
Publicado: (2016)

Multi-Stress Induction of the Mycobacterium tuberculosis MbcTA Bactericidal Toxin-Antitoxin System
por: Ariyachaokun, Kanchiyaphat, et al.
Publicado: (2020)

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Screening the Toxicity of Selected Personal Care Products Using Embryo Bioassays: 4-MBC, Propylparaben and Triclocarban
por: Torres, Tiago, et al.
Publicado: (2016)

Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC
por: Parry, Marina
Publicado: (2018)

Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient – a case report
por: Ramaswamy, Rajkumar, et al.
Publicado: (2019)

The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus
por: Parvekar, Prashik, et al.
Publicado: (2020)

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
por: Trevisan, B., et al.
Publicado: (2023)

Radiotherapy in Current Neuro-Oncology: There Is Still Much to Reveal
por: Ferini, Gianluca, et al.
Publicado: (2021)

Comment on Ivanov et al. Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic. Medicina 2022, 58, 745
por: Ferini, Gianluca
Publicado: (2022)

A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC)
por: Yu, Xing-Fei, et al.
Publicado: (2015)

Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience †
por: Andrahennadi, Samitha, et al.
Publicado: (2021)

Hypothesis of a decision-making algorithm for adjuvant radiotherapy in left-sided breast cancer patients
por: Ferini, Gianluca, et al.
Publicado: (2021)

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
por: Bensalem, A, et al.
Publicado: (2005)

Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC
por: Colomer, R., et al.
Publicado: (2017)

The Foodborne Strain Lactobacillus fermentum MBC2 Triggers pept-1-Dependent Pro-Longevity Effects in Caenorhabditis elegans
por: Schifano, Emily, et al.
Publicado: (2019)

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)
por: Pérol, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j58gqc0c5ia9fgmiudf3jdoi65